{"id":"https://openalex.org/W2066015259","doi":"https://doi.org/10.1093/jnci/93.15.1120","title":"Are Patterns of HER-2/neu Amplification and Expression Among Primary Tumors and Regional Metastases Indicative of Those in Distant Metastases and Predictive of Herceptin Response?","display_name":"Are Patterns of HER-2/neu Amplification and Expression Among Primary Tumors and Regional Metastases Indicative of Those in Distant Metastases and Predictive of Herceptin Response?","publication_year":2001,"publication_date":"2001-08-01","ids":{"openalex":"https://openalex.org/W2066015259","doi":"https://doi.org/10.1093/jnci/93.15.1120","mag":"2066015259","pmid":"https://pubmed.ncbi.nlm.nih.gov/11481375"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/93.15.1120","doi":"https://doi.org/10.1093/jnci/93.15.1120","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/93.15.1120","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"volume":null,"type":"editorial","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013400628","display_name":"Ann D. Thor","orcid":"https://orcid.org/0000-0001-7725-1869","observed_orcids":["https://orcid.org/0000-0001-7725-1869"]},"institutions":[{"id":"https://openalex.org/I8692664","display_name":"University of Oklahoma","ror":"https://ror.org/02aqsxs83","country_code":"US","type":"education","lineage":["https://openalex.org/I8692664"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"A. Thor","raw_affiliation_strings":["Correspondence to: Ann Thor, M.D., University of Oklahoma College of Medicine, 940 Stanton L. Young Blvd., BMSB 451, Oklahoma City, OK 73104","University of Oklahoma College of Medicine, 940 Stanton L. Young Blvd., BMSB 451, Oklahoma City, OK 73104"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Correspondence to: Ann Thor, M.D., University of Oklahoma College of Medicine, 940 Stanton L. Young Blvd., BMSB 451, Oklahoma City, OK 73104","institution_ids":["https://openalex.org/I8692664"]},{"raw_affiliation_string":"University of Oklahoma College of Medicine, 940 Stanton L. Young Blvd., BMSB 451, Oklahoma City, OK 73104","institution_ids":["https://openalex.org/I8692664"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5013400628"],"corresponding_institution_ids":["https://openalex.org/I8692664"],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":26,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"93","issue":"15","first_page":"1120","last_page":"1121"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-neu","display_name":"HER2/neu","score":0.9810000061988831},{"id":"https://openalex.org/keywords/gene-amplification","display_name":"gene amplification","score":0.7459999918937683},{"id":"https://openalex.org/keywords/protein-overexpression","display_name":"protein overexpression","score":0.9800000190734863},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.968999981880188},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8230000138282776},{"id":"https://openalex.org/keywords/distant-metastasis","display_name":"distant metastasis","score":0.8330000042915344},{"id":"https://openalex.org/keywords/regional-metastases","display_name":"regional metastases","score":0.9190000295639038},{"id":"https://openalex.org/keywords/primary-tumor","display_name":"primary tumor","score":0.7850000262260437},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.8349999785423279},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.44600000977516174}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.6846258640289307},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5734509825706482},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5576265454292297},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.5483813285827637},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.4746202528476715},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.46703171730041504},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.46602439880371094},{"id":"https://openalex.org/C2780849966","wikidata":"https://www.wikidata.org/wiki/Q170758","display_name":"Lymph node","level":2,"score":0.4553064703941345},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45204076170921326},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.43958359956741333},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42718714475631714},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4149627685546875},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.41401544213294983},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3867890238761902},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.3501047194004059},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.25544142723083496}],"mesh":[{"descriptor_ui":"D000068878","descriptor_name":"Trastuzumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005784","descriptor_name":"Gene Amplification","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008207","descriptor_name":"Lymphatic Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017404","descriptor_name":"In Situ Hybridization, Fluorescence","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D018734","descriptor_name":"Genes, erbB-2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1093/jnci/93.15.1120","doi":"https://doi.org/10.1093/jnci/93.15.1120","is_oa":false,"landing_page_url":"https://doi.org/10.1093/jnci/93.15.1120","pdf_url":null,"source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:11481375","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11481375","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Comment"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.543.4049","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.543.4049","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnci.oxfordjournals.org/content/93/15/1120.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1705540744","https://openalex.org/W1755920412","https://openalex.org/W1904016327","https://openalex.org/W1976052438","https://openalex.org/W2026864697","https://openalex.org/W2105496184","https://openalex.org/W2156082673","https://openalex.org/W2156544288","https://openalex.org/W2164789874","https://openalex.org/W2167167632","https://openalex.org/W3128877721"],"related_works":["https://openalex.org/W7099893137","https://openalex.org/W1973460244","https://openalex.org/W4211061808","https://openalex.org/W2297814107","https://openalex.org/W2424915846","https://openalex.org/W81865859","https://openalex.org/W2154568434","https://openalex.org/W2128448303","https://openalex.org/W7097831344","https://openalex.org/W112854329"],"abstract_inverted_index":{"HER-2/neu":[0],"(ERB-B2),":[1],"a":[2,19,58,88,124,147,203,222,238],"member":[3],"of":[4,22,52,71,78,118,136,240,263],"the":[5,69,76,97,116,134,144],"receptor":[6,109],"tyrosine":[7],"kinase":[8],"superfamily,":[9],"is":[10,57,64,187],"altered":[11,198],"by":[12],"gene":[13,73,140],"amplification":[14,74],"and/or":[15,75],"protein":[16,80],"overexpression":[17],"in":[18,48,115,236],"wide":[20],"variety":[21],"human":[23],"epithelial":[24],"malignancies.":[25],"Such":[26],"alterations":[27,121],"activate":[28],"signaling":[29],"systems":[30],"that":[31,63,146,194,225],"promote":[32],"cell":[33],"growth,":[34],"angiogenesis,":[35],"cancer":[36,92,252],"metastases,":[37],"and":[38,60,106,111,143,166,181],"other":[39,169,257],"procarcinogenic":[40],"pathways":[41],"(1).":[42],"These":[43],"HER-2":[44,55,72,82,120,137,164,199,208,229],"abnormalities":[45],"are":[46],"found":[47,132],"approximately":[49],"one":[50],"third":[51],"breast":[53,91,246,251],"cancers.":[54],"\u201cstatus\u201d":[56],"loose":[59],"suboptimal":[61],"term":[62],"commonly":[65],"used":[66,86],"to":[67,96,192,259],"describe":[68],"degree":[70,135],"extent":[77],"Her-2":[79],"overexpression.":[81],"status":[83,165,200],"has":[84,209,233],"been":[85,131,174],"as":[87,219,227],"marker":[89],"for":[90,214],"prognosis":[93],"(in":[94],"addition":[95],"classic":[98],"markers":[99],"lymph":[100],"node":[101],"status,":[102,110],"tumor":[103],"size,":[104],"type":[105],"grade,":[107],"hormone":[108],"proliferation":[112],"rate),":[113],"because,":[114],"majority":[117],"cases,":[119],"independently":[122],"portend":[123],"worse":[125],"outcome.":[126,205],"In":[127],"addition,":[128],"associations":[129],"have":[130,172,202],"between":[133,163],"expression":[138],"or":[139],"copy":[141],"number":[142],"likelihood":[145],"patient":[148],"may":[149],"derive":[150],"benefit":[151],"from":[152],"some":[153],"chemotherapy":[154],"regimens,":[155],"i.e.,":[156],"predictive":[157],"value":[158],"(2\u20134).":[159],"Statistically":[160],"significant":[161],"interactions":[162,180],"chemotherapeutic":[167],"agents":[168,258],"than":[170],"anthracyclines":[171],"also":[173],"reported":[175],"(5).":[176],"Given":[177],"these":[178],"chemotherapeutic/HER-2":[179],"new":[182],"anti-HER-2":[183],"therapeutic":[184,216],"agents,":[185],"it":[186],"no":[188],"longer":[189],"always":[190],"correct":[191],"assume":[193],"cancers":[195],"with":[196,242,256],"an":[197,211,228],"will":[201],"poor":[204],"As":[206],"noted,":[207],"become":[210],"important":[212],"target":[213],"novel":[215],"strategies,":[217],"such":[218],"trastuzumab":[220],"(Herceptin),":[221],"monoclonal":[223],"antibody":[224],"acts":[226],"antagonist.":[230],"This":[231],"agent":[232],"shown":[234],"promise":[235],"treating":[237],"subset":[239],"patients":[241],"otherwise":[243],"chemorefractory,":[244],"late-stage":[245],"cancer.":[247],"Many":[248],"recently":[249],"opened":[250],"trials":[253],"combine":[254],"Herceptin":[255],"treat":[260],"various":[261],"stages":[262],"disease.":[264]},"counts_by_year":[{"year":2018,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}